For COVID-19 vaccine updates, please review our information guide and sign up for Connect. Continue your routine care with us by scheduling an in-person appointment or Video Visit.
Osseointegrated bone conduction devices are FDA-approved, surgically implanted titanium posts or internal magnets that connect to an external digital processing device. This instrument is programmed in accordance with a patient’s hearing loss and allows sound to be conducted through the patient's mastoid directly to the inner ear.
Osseointegrated bone conduction devices are used in patients with:
For conductive or mixed hearing loss, sound enters the device on the side of the impaired ear and is transmitted via bone conduction to the cochlea on the same side. For single-sided deafness or unilateral hearing loss, sound enters the device on the side of the impaired ear and is transmitted via bone conduction to the cochlea of the opposite (better functioning) ear.
Osseointegrated bone conduction device implantation is FDA-approved for:
To be considered for an osseointegrated bone conduction device, you will need a:
Patients who receive an osseointegrated bone conduction device will require: